Mounjaro is the UK brand name of the drug tirzepatide ... showing promise in clinical trials—such as an oral weight loss pill. Having alternative products available will ease strain on the ...

Fact checked by Nick BlackmerMultiple pharmaceutical companies are developing oral versions of GLP-1 medications like Ozempic ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

How it works: VK2735 acts on both GLP-1 and GIP, similar to tirzepatide (the active ingredient in Mounjaro and Zepbound). It's being tested in pill form as well as a once-weekly injection.

Mounjaro, however targets both GLP-1 and GIP ... Similar concerns arose for its oral weight-loss pill. Weight loss jabs will not be a ‘holy grail’ for weight management services, a top ...

A diabetes medicine dubbed the "King Kong" of weight loss jabs has been approved in the UK for treating obesity. Mounjaro, or tirzepatide, makes you feel fuller so you eat less. In trials, people ...

Mounjaro, which treats type 2 diabetes ... effects and a long term commitment of lifestyle changes.” Adding: “Pills, on the other hand can be a convenient option, but may offer less dramatic ...